ImmuCell Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3.89	3.76	0.98	5.79	10.19	6.95
Short-Term Investments	-	-	-	-	-	1
Cash & Short-Term Investments	3.89	3.76	0.98	5.79	10.19	7.95
Cash Growth	2.04%	283.99%	-83.10%	-43.14%	28.18%	-9.43%
Accounts Receivable	2.55	3.77	2.19	1.76	2.69	1.8
Other Receivables	0.05	0.04	0.04	0.04	0.03	0.07
Receivables	2.61	3.81	2.23	1.8	2.72	1.86
Inventory	9.8	7.11	7.81	6.04	3.09	2.09
Prepaid Expenses	0.53	0.36	0.45	0.36	0.27	0.25
Other Current Assets	-	-	-	-	-	0
Total Current Assets	16.83	15.04	11.47	13.99	16.26	12.16
Property, Plant & Equipment	28.76	29.91	32.15	30.64	28	27.98
Goodwill	0.1	0.1	0.1	0.1	0.1	0.1
Other Intangible Assets	0	0.02	0.04	0.06	0.08	0.1
Other Long-Term Assets	0.04	0.03	0.06	0.08	0.03	0.03
Total Assets	45.73	45.1	43.81	44.86	44.47	40.35
Accounts Payable	0.95	0.93	0.87	0.73	0.73	0.6
Accrued Expenses	1.35	1.53	1.23	1.21	0.87	0.75
Current Portion of Long-Term Debt	1.59	1.5	1.43	1.04	0.81	0.76
Current Portion of Leases	0.08	0.43	0.64	0.03	0.11	0.1
Current Income Taxes Payable	0	0.01	0	0	0	-
Other Current Liabilities	0.02	0.01	0.01	0.06	0.02	-
Total Current Liabilities	4	4.41	4.2	3.07	2.53	2.21
Long-Term Debt	7.9	9.04	10.54	9.19	8.33	8.74
Long-Term Leases	4.03	4.13	4.08	2.22	1.03	1.14
Total Liabilities	15.93	17.58	18.82	14.48	11.89	12.08
Common Stock	0.91	0.9	0.78	0.78	0.78	0.73
Additional Paid-In Capital	41.38	40.92	36.36	35.98	35.69	31.37
Retained Earnings	-12.35	-14.16	-12.01	-6.23	-3.74	-3.66
Treasury Stock	-0.13	-0.14	-0.14	-0.15	-0.16	-0.18
Shareholders' Equity	29.8	27.52	24.99	30.38	32.58	28.27
Total Liabilities & Equity	45.73	45.1	43.81	44.86	44.47	40.35
Total Debt	13.61	15.1	16.69	12.48	10.27	10.73
Net Cash (Debt)	-9.72	-11.34	-15.71	-6.69	-0.09	-2.79
Net Cash Per Share	-1.08	-1.39	-2.03	-0.86	-0.01	-0.39
Filing Date Shares Outstanding	9.05	8.98	7.75	7.75	7.74	7.22
Total Common Shares Outstanding	9.05	8.98	7.75	7.75	7.74	7.22
Working Capital	12.83	10.63	7.27	10.92	13.73	9.95
Book Value Per Share	3.29	3.06	3.22	3.92	4.21	3.92
Tangible Book Value	29.7	27.4	24.86	30.23	32.4	28.08
Tangible Book Value Per Share	3.28	3.05	3.21	3.90	4.19	3.89
Land	0.52	0.52	0.52	0.52	0.52	0.52
Buildings	20.96	20.89	20.78	20.05	19.12	19
Machinery	21.82	22.29	21.99	20.08	18.26	16.57
Construction In Progress	2.65	2.69	2.77	3.67	2.99	2.34
Order Backlog	-	4.4	9.4	2.5	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q